We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$47.2B
AUM Growth
+$8.08B
Cap. Flow
+$2.33B
Cap. Flow %
4.95%
Top 10 Hldgs %
35.89%
Holding
5,834
New
1,032
Increased
1,743
Reduced
1,554
Closed
961

Sector Composition

Rank Sector Weight
1 Technology 2.27%
2 Financials 2.09%
3 Healthcare 1.72%
4 Consumer Discretionary 1.48%
5 Industrials 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALY
3276
CALL
Callaway Golf Company
CALY
$3.32B
$311K ﹤0.01%
21,700
-3,900
-15% -$50.1K
MORF
3277
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$311K ﹤0.01%
10,767
-159,832
-94% -$3.81M
NWSA icon
3278
CALL
News Corp Class A
NWSA
$14.9B
$309K ﹤0.01%
+12,600
New +$274K
FIRY
3279
CALL
Firy Inc
FIRY
$148M
$309K ﹤0.01%
49,500
+43,500
+725% +$243K
BITO icon
3280
ProShares Bitcoin Strategy ETF
BITO
$1.41B
$309K ﹤0.01%
+15,062
New +$273K
TDCX
3281
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$309K ﹤0.01%
63,623
+11,210
+21% +$55K
MBIN icon
3282
Merchants Bancorp
MBIN
$2.53B
$308K ﹤0.01%
7,244
-1,651
-19% -$54.3K
FIP icon
3283
FTAI Infrastructure
FIP
$441M
$308K ﹤0.01%
+79,285
New +$278K
NVEI
3284
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$307K ﹤0.01%
11,708
-24,339
-68% -$467K
IMCR icon
3285
CALL
Immunocore
IMCR
$1.72B
$307K ﹤0.01%
4,500
+2,300
+105% +$120K
INSP icon
3286
CALL
Inspire Medical Systems
INSP
$1.45B
$305K ﹤0.01%
1,500
-1,000
-40% -$162K
BZ icon
3287
Kanzhun
BZ
$7.27B
$305K ﹤0.01%
18,347
-177,037
-91% -$2.78M
CBAY
3288
CALL
DELISTED
Cymabay Therapeutics
CBAY
$305K ﹤0.01%
+12,900
New +$230K
CBAY
3289
PUT
DELISTED
Cymabay Therapeutics
CBAY
$305K ﹤0.01%
+12,900
New +$230K
EXEL icon
3290
PUT
Exelixis
EXEL
$13.3B
$305K ﹤0.01%
12,700
-26,700
-68% -$580K
MSM icon
3291
CALL
MSC Industrial Direct
MSM
$6.89B
$304K ﹤0.01%
+3,000
New +$297K
ETR icon
3292
CALL
Entergy
ETR
$50.2B
$304K ﹤0.01%
6,000
+1,800
+43% +$87.9K
TXG icon
3293
CALL
10x Genomics
TXG
$6B
$302K ﹤0.01%
5,400
-500
-8% -$21.8K
MCS icon
3294
Marcus Corp
MCS
$897M
$302K ﹤0.01%
+20,719
New +$310K
EME icon
3295
Emcor
EME
$35.2B
$302K ﹤0.01%
+1,400
New +$294K
RARE icon
3296
PUT
Ultragenyx Pharmaceutical
RARE
$2.45B
$301K ﹤0.01%
6,300
-100
-2% -$3.88K
SGI
3297
CALL
Somnigroup International
SGI
$13.7B
$301K ﹤0.01%
5,900
-5,300
-47% -$225K
AXTI icon
3298
AXT Inc
AXTI
$3.95B
$300K ﹤0.01%
124,978
-83,722
-40% -$187K
AVB icon
3299
CALL
AvalonBay Communities
AVB
$26.5B
$300K ﹤0.01%
1,600
-4,300
-73% -$750K
VNO icon
3300
PUT
Vornado Realty Trust
VNO
$7.41B
$299K ﹤0.01%
+10,600
New +$252K

Similar funds

Walleye Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Walleye Capital held 5,834 positions worth $47.2B, up 21% from $39.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Walleye Capital deployed $2.33B of net new capital in Q4 2023, opening 1,032 new positions and adding to 1,743 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $59.4M trimmed.

  • Walleye Capital's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
  • Walleye Capital added most to Lam Research in Q4 2023, an estimated $51.4M increase.
  • Walleye Capital's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $59.4M.
  • Walleye Capital fully exited VMware, Inc in Q4 2023, selling an estimated $57.2M.
  • Walleye Capital's ten largest holdings make up 36% of its $47.2B portfolio in Q4 2023.
  • Walleye Capital opened 1,032 new positions and closed 961 in Q4 2023.
  • Walleye Capital's portfolio value rose 21% quarter-over-quarter to $47.2B.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.